Nanomedicine in coronary artery disease
2017-07-13
org.kosen.entty.User@70993a0
김정실(initial)
분야
생명과학
개최일
2017.3
신청자
김정실(initial)
개최장소
URL
행사&학회소개
1. Introduction
2. Historical context
2.1. Role of nanomedicine in targeted drug delivery
2.2. The global burden of Coronary artery disease (CAD)
2.3. Coronary artery disease and nanomedicine
2.4. Development of Coronary artery disease
2.5. Non-invasive nanomedicine strategies
2.5.1. Affecting lipid levels
2.5.2. Affecting angiogenesis
2.5.3. Affecting inflammation
2.5.4. Affecting intra-arterial thrombosis
2.6. Invasive nanomedicine therapeutic strategies
2.6.1. Anti-restenosis strategy following PCI
2.6.2. Prevention of in-stent restenosis
2.6.3. Healing enchancement strategy following PCI
2.6.4. CABG biosynthetic grafts using nanotechnology
2.7. Nanomedicine and imaging
2.8. Challenges in application of nanomedicine
2.8.1. Development
2.8.2. Age of nanomaterials in vivo
2.8.3. Biological side effects
2.8.4. Direct toxicity
2.9. Future of nanomedicine in CAD therapy
2. Historical context
2.1. Role of nanomedicine in targeted drug delivery
2.2. The global burden of Coronary artery disease (CAD)
2.3. Coronary artery disease and nanomedicine
2.4. Development of Coronary artery disease
2.5. Non-invasive nanomedicine strategies
2.5.1. Affecting lipid levels
2.5.2. Affecting angiogenesis
2.5.3. Affecting inflammation
2.5.4. Affecting intra-arterial thrombosis
2.6. Invasive nanomedicine therapeutic strategies
2.6.1. Anti-restenosis strategy following PCI
2.6.2. Prevention of in-stent restenosis
2.6.3. Healing enchancement strategy following PCI
2.6.4. CABG biosynthetic grafts using nanotechnology
2.7. Nanomedicine and imaging
2.8. Challenges in application of nanomedicine
2.8.1. Development
2.8.2. Age of nanomaterials in vivo
2.8.3. Biological side effects
2.8.4. Direct toxicity
2.9. Future of nanomedicine in CAD therapy
보고서작성신청
관상동맥질환의 치료를 위한 나노의학기술 응용에 대한 리뷰논문입니다.